Restricted accessResearch articleFirst published online 2020-07
Abrogation of Toll-Like Receptor 4 Mitigates Obesity-Induced Oxidative Stress,Proinflammation,and Insulin Resistance Through Metabolic Reprogramming of Mitochondria in Adipose Tissue
Obesity-induced excessive visceral fat (VF) accumulation is associated with insulin resistance (IR), systemic oxidative stress, and chronic inflammation. As toll-like receptor 4 (TLR4) plays an important role in innate immunity, we herein investigate the effect of TLR4 knockout (T4KO) in a high-fat high-sucrose diet (HFD)-induced obesity mouse model.
Results:
C57BL6 wild-type (WT) and T4KO mice were fed with either control diet (CD) or HFD for 12 months, rendering four experimental groups: WT+CD, WT+HFD, T4KO+CD, and T4KO+HFD. Compared with WT+CD, WT+HFD demonstrated significant increase in VF accumulation, oxidative damage, M1/M2 macrophage ratio, chronic inflammation, and development of IR. Compared with WT+HFD, T4KO+HFD presented increased BW and body fat with higher subcutaneous fat (SF)/VF ratio, but lower body temperature, as well as decreased oxidative damage, M1/M2 macrophage ratio, chronic inflammation, and IR. Unlike WT+HFD, T4KO+HFD exhibited an increase in mitochondrial electron transport chain activity but a decrease of uncoupling protein 2 (UCP2) level. While T4KO hindered HFD-induced increasing mitochondrial oxygen consumption rate, a shift toward a higher extracellular acidification rate in VF was observed. Notably, T4KO inhibits HFD-induced mitochondrial translocation of nuclear factor of activated T cells 2 (NFATC2), which contributed to mitochondrial metabolic reprogramming. Both fat distribution shifting from VF to SF and mitochondrial metabolic reprogramming may alleviate systemic oxidative stress and chronic inflammation.
Innovation and Conclusion:
Abrogation of TLR4 contributes to reduction of oxidative stress through metabolic reprogramming of mitochondria in VF, mitigating obesity-induced IR. The study provides critical insight into associating innate immunity–mitochondria interplay with prevention of diabetes.
Get full access to this article
View all access options for this article.
References
1.
AbateN, GargA, PeshockRM, Stray-GundersenJ, and GrundySM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest, 96: 88–98, 1995.
AppariM, ChannonKM, and McNeillE. Metabolic regulation of adipose tissue macrophage function in obesity and diabetes. Antioxid Redox Signal, 29: 297–312, 2018.
5.
BauerfeldCP, RastogiR, PirockinaiteG, LeeI, HuttemannM, MonksB, BirnbaumMJ, FranchiL, NunezG, and SamavatiL. TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages. J Immunol, 188: 2847–2857, 2012.
6.
BredaCNS, DavanzoGG, BassoPJ, Saraiva CamaraNO, and Moraes-VieiraPMM. Mitochondria as central hub of the immune system. Redox Biol, 26: 101255, 2019.
7.
CareyVJ, WaltersEE, ColditzGA, SolomonCG, WillettWC, RosnerBA, SpeizerFE, and MansonJE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol, 145: 614–619, 1997.
8.
CaronA, LabbeSM, CarterS, RoyMC, LecomteR, RicquierD, PicardF, and RichardD. Loss of UCP2 impairs cold-induced non-shivering thermogenesis by promoting a shift toward glucose utilization in brown adipose tissue. Biochimie, 134: 118–126, 2017.
9.
CaselliC. Role of adiponectin system in insulin resistance. Mol Genet Metab, 113: 155–160, 2014.
10.
CerielloA, IhnatMA, and ThorpeJE. Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications?. J Clin Endocrinol Metab, 94: 410–415, 2009.
11.
ChavezJA, KnottsTA, WangLP, LiG, DobrowskyRT, FlorantGL, and SummersSA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem, 278: 10297–10303, 2003.
12.
ChenY, ZhouZ, and MinW. Mitochondria, oxidative stress and innate immunity. Front Physiol, 9: 1487, 2018.
13.
ChrysohoouC, PanagiotakosDB, AggelopoulosP, KastoriniCM, KehagiaI, PitsavosC, and StefanadisC. The Mediterranean diet contributes to the preservation of left ventricular systolic function and to the long-term favorable prognosis of patients who have had an acute coronary event. Am J Clin Nutr, 92: 47–54, 2010.
14.
DavisJE, GablerNK, Walker-DanielsJ, and SpurlockME. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring), 16: 1248–1255, 2008.
15.
DespresJP, LemieuxI, and Prud'hommeD. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ, 322: 716–720, 2001.
DivellaR, De LucaR, AbbateI, NaglieriE, and DanieleA. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer, 7: 2346–2359, 2016.
18.
DonathMY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov, 13: 465–476, 2014.
19.
FangY, WangS, ZhuT, ZhangY, and LianX. Atherogenic high cholesterol/high fat diet induces TLRs-associated pulmonary inflammation in C57BL/6J mice. Inflamm Res, 66: 39–47, 2017.
20.
FrisardMI, WuY, McMillanRP, VoelkerKA, WahlbergKA, AndersonAS, BoutagyN, ResendesK, RavussinE, and HulverMW. Low levels of lipopolysaccharide modulate mitochondrial oxygen consumption in skeletal muscle. Metabolism, 64: 416–427, 2015.
HolmanRR, PaulSK, BethelMA, MatthewsDR, and NeilHA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 359: 1577–1589, 2008.
23.
HotamisligilGS. Inflammation, metaflammation and immunometabolic disorders. Nature, 542: 177–185, 2017.
24.
HuangZH, ManickamB, RyvkinV, ZhouXJ, FantuzziG, MazzoneT, and SamS. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity. J Clin Endocrinol Metab, 98: E17–E24, 2013.
25.
HyakkokuK, HamanakaJ, TsurumaK, ShimazawaM, TanakaH, UematsuS, AkiraS, InagakiN, NagaiH, and HaraH. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience, 171: 258–267, 2010.
26.
JiY, SunS, ShresthaN, DarraghLB, ShirakawaJ, XingY, HeY, CarboneauBA, KimH, AnD, MaM, OberholzerJ, SoleimanpourSA, GannonM, LiuC, NajiA, KulkarniRN, WangY, KerstenS, and QiL. Toll-like receptors TLR2 and TLR4 block the replication of pancreatic beta cells in diet-induced obesity. Nat Immunol, 20: 677–686, 2019.
27.
JialalI, KaurH, and DevarajS. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab, 99: 39–48, 2014.
28.
KimF, PhamM, LuttrellI, BannermanDD, TupperJ, ThalerJ, HawnTR, RainesEW, and SchwartzMW. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res, 100: 1589–1596, 2007.
29.
KimJJ and SearsDD. TLR4 and insulin resistance. Gastroenterol Res Pract 2010: pii: 212563, 2010.
30.
KimJK. Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab, 4: 417–419, 2006.
31.
KimKA, GuW, LeeIA, JohEH, and KimDH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 7: e47713, 2012.
32.
KoMK, SaraswathyS, ParikhJG, and RaoNA. The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest Ophthalmol Vis Sci, 52: 5824–5835, 2011.
33.
KonnerAC and BruningJC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab, 22: 16–23, 2011.
34.
KukJL, KatzmarzykPT, NichamanMZ, ChurchTS, BlairSN, and RossR. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring), 14: 336–341, 2006.
35.
KwonOS, NelsonDS, BarrowsKM, O'ConnellRM, and DrummondMJ. Intramyocellular ceramides and skeletal muscle mitochondrial respiration are partially regulated by Toll-like receptor 4 during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol, 311: R879–R887, 2016.
36.
LeeJJ, WangPW, YangIH, HuangHM, ChangCS, WuCL, and ChuangJH. High-fat diet induces toll-like receptor 4-dependent macrophage/microglial cell activation and retinal impairment. Invest Ophthalmol Vis Sci, 56: 3041–3050, 2015.
37.
LestradetH. [Diet regimen and long-term prognosis in juvenile diabetes]. Arch Fr Pediatr, 36: 49–55, 1979.
38.
LiuJ, FoxCS, HicksonDA, MayWD, HairstonKG, CarrJJ, and TaylorHA. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab, 95: 5419–5426, 2010.
39.
LiuJ, ZhuangZJ, BianDX, MaXJ, XunYH, YangWJ, LuoY, LiuYL, JiaL, WangY, ZhuML, YeDW, ZhouG, LouGQ, and ShiJP. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. Clin Exp Pharmacol Physiol, 41: 482–488, 2014.
40.
LumengCN, BodzinJL, and SaltielAR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest, 117: 175–184, 2007.
41.
MaB, YuJ, XieC, SunL, LinS, DingJ, LuoJ, and CaiH. Toll-like receptors promote mitochondrial translocation of nuclear transcription factor nuclear factor of activated T-cells in prolonged microglial activation. J Neurosci, 35: 10799–10814, 2015.
42.
MarinTL, GongolB, ZhangF, MartinM, JohnsonDA, XiaoH, WangY, SubramaniamS, ChienS, and ShyyJY. AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1. Sci Signal 10: pii: eaaf7478, 2017.
43.
McLaughlinT, LamendolaC, LiuA, and AbbasiF. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab, 96: E1756–E1760, 2011.
44.
MisraA, GargA, AbateN, PeshockRM, Stray-GundersenJ, and GrundySM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res, 5: 93–99, 1997.
45.
MoriyamaM, MoriyamaH, UdaJ, KuboH, NakajimaY, GotoA, MoritaT, and HayakawaT. BNIP3 upregulation via stimulation of ERK and JNK activity is required for the protection of keratinocytes from UVB-induced apoptosis. Cell Death Dis, 8: e2576, 2017.
46.
NicklasBJ, CesariM, PenninxBW, KritchevskySB, DingJ, NewmanA, KitzmanDW, KanayaAM, PahorM, and HarrisTB. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc, 54: 413–420, 2006.
47.
NiemannB, RohrbachS, MillerMR, NewbyDE, FusterV, and KovacicJC. Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: part 3 of a 3-part series. J Am Coll Cardiol, 70: 230–251, 2017.
48.
OrrJS, PuglisiMJ, EllacottKL, LumengCN, WassermanDH, and HastyAH. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes, 61: 2718–2727, 2012.
49.
PanagiotakosDB, ArapiS, PitsavosC, AntonoulasA, MantasY, ZombolosS, and StefanadisC. The relationship between adherence to the Mediterranean diet and the severity and short-term prognosis of acute coronary syndromes (ACS): the Greek Study of ACS (The GREECS). Nutrition, 22: 722–730, 2006.
50.
PanagiotakosDB, PitsavosC, StefanadisC, and InvestigatorsGS. Short-term prognosis of patients with acute coronary syndromes through the evaluation of physical activity status, the adoption of Mediterranean diet and smoking habits: the Greek Acute Coronary Syndromes (GREECS) study. Eur J Cardiovasc Prev Rehabil, 13: 901–908, 2006.
51.
RabinovitchRC, SamborskaB, FaubertB, MaEH, GravelSP, AndrzejewskiS, RaissiTC, PauseA, St-PierreJ, and JonesRG. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep, 21: 1–9, 2017.
52.
RadinMS, SinhaS, BhattBA, DedousisN, and O'DohertyRM. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia, 51: 336–346, 2008.
53.
RazolliDS, MoraesJC, MorariJ, MouraRF, VinoloMA, and VellosoLA. TLR4 expression in bone marrow-derived cells is both necessary and sufficient to produce the insulin resistance phenotype in diet-induced obesity. Endocrinology, 156: 103–113, 2015.
54.
RiusJ, GumaM, SchachtrupC, AkassoglouK, ZinkernagelAS, NizetV, JohnsonRS, HaddadGG, and KarinM. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 453: 807–811, 2008.
55.
Schmitz-PeifferC, CraigDL, and BidenTJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem, 274: 24202–24210, 1999.
56.
ShenXD, KeB, ZhaiY, GaoF, TsuchihashiS, LassmanCR, BusuttilRW, and Kupiec-WeglinskiJW. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transpl, 13: 1435–1443, 2007.
SnijderMB, DekkerJM, VisserM, BouterLM, StehouwerCD, KostensePJ, YudkinJS, HeineRJ, NijpelsG, and SeidellJC. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr, 77: 1192–1197, 2003.
59.
SunS, JiY, KerstenS, and QiL. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr, 32: 261–286, 2012.
60.
ThompsonAL, Lim-FraserMY, KraegenEW, and CooneyGJ. Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro. Am J Physiol Endocrinol Metab, 279: E577–E584, 2000.
61.
TianXY, MaS, TseG, WongWT, and HuangY. Uncoupling protein 2 in cardiovascular health and disease. Front Physiol, 9: 1060, 2018.
62.
TishinskyJM, De BoerAA, DyckDJ, and RobinsonLE. Modulation of visceral fat adipokine secretion by dietary fatty acids and ensuing changes in skeletal muscle inflammation. Appl Physiol Nutr Metab, 39: 28–37, 2014.
63.
TramullasM, FingerBC, DinanTG, and CryanJF. Obesity takes its toll on visceral pain: high-fat diet induces toll-like receptor 4-dependent visceral hypersensitivity. PLoS One, 11: e0155367, 2016.
64.
VilaIK, BadinPM, MarquesMA, MonbrunL, LefortC, MirL, LoucheK, BourlierV, RousselB, GuiP, GroberJ, StichV, RossmeislovaL, Zakaroff-GirardA, BouloumieA, ViguerieN, MoroC, TavernierG, and LanginD. Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis. Cell Rep, 7: 1116–1129, 2014.
65.
WangC, HaX, LiW, XuP, GuY, WangT, WangY, XieJ, and ZhangJ. Correlation of TLR4 and KLF7 in inflammation induced by obesity. Inflammation, 40: 42–51, 2017.
66.
WangPW, KuoHM, HuangHT, ChangAY, WengSW, TaiMH, ChuangJH, ChenIY, HuangSC, LinTK, and LiouCW. Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice. Antioxid Redox Signal, 20: 2572–2588, 2014.
67.
WangY, RimmEB, StampferMJ, WillettWC, and HuFB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr, 81: 555–563, 2005.
68.
WestAP, BrodskyIE, RahnerC, WooDK, Erdjument-BromageH, TempstP, WalshMC, ChoiY, ShadelGS, and GhoshS. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature, 472: 476–480, 2011.
69.
YangTT, SukHY, YangX, OlabisiO, YuRY, DurandJ, JelicksLA, KimJY, SchererPE, WangY, FengY, RossettiL, GraefIA, CrabtreeGR, and ChowCW. Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol, 26: 7372–7387, 2006.
70.
YuL, WangL, and ChenS. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med, 14: 2592–2603, 2010.
71.
ZanoniI and GranucciF. Regulation and dysregulation of innate immunity by NFAT signaling downstream of pattern recognition receptors (PRRs). Eur J Immunol, 42: 1924–1931, 2012.
72.
ZhaJM, DiWJ, ZhuT, XieY, YuJ, LiuJ, ChenP, and DingG. Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults. Endocr J, 56: 935–944, 2009.
73.
ZhongZ, LiangS, Sanchez-LopezE, HeF, ShalapourS, LinXJ, WongJ, DingS, SekiE, SchnablB, HevenerAL, GreenbergHB, KisselevaT, and KarinM. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature, 560: 198–203, 2018.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
